Cary Street Partners Investment Advisory’s Biogen BIIB Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76.3K	Buy	353 +69	+24%	+$13.2K	0.02%	539
2026 Q1	$52.1K	Buy	284 +37	+15%	+$6.82K	0.01%	534
2025 Q4	$43.5K	Buy	247 +138	+127%	+$22.5K	0.01%	526
2025 Q3	$15.3K	Buy	+109	New	+$14.7K	0.01%	525
2025 Q1	–	Sell	-195	Closed	-$29.8K	–	568
2024 Q4	$29.8K	Sell	195 -1,706	-90%	-$288K	0.02%	371
2024 Q3	$368K	Buy	1,901 +57	+3%	+$11.9K	0.01%	568
2024 Q2	$427K	Buy	1,844 +19	+1%	+$4.13K	0.02%	510
2024 Q1	$394K	Sell	1,825 -8	-0.4%	-$1.87K	0.02%	507
2023 Q4	$474K	Sell	1,833 -122	-6%	-$30K	0.02%	435
2023 Q3	$502K	Buy	1,955 +45	+2%	+$12K	0.03%	400
2023 Q2	$544K	Hold	1,910	–	–	0.04%	344
2023 Q1	$531K	Hold	1,910	–	–	0.04%	327
2022 Q4	$529K	Sell	1,910 -13	-0.7%	-$3.67K	0.04%	325
2022 Q3	$513K	Buy	1,923 +207	+12%	+$44K	0.04%	308
2022 Q2	$350K	Buy	+1,716	New	+$351K	0.03%	336
2021 Q3	–	Sell	-120	Closed	-$42K	–	256
2021 Q2	$42K	Buy	120 +5	+4%	+$1.51K	0.01%	292
2021 Q1	$32K	Buy	+115	New	+$31K	0.01%	282
2020 Q4	–	Sell	-4,764	Closed	-$1.35M	–	405
2020 Q3	$1.35M	Buy	+4,764	New	+$1.33M	0.29%	107

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Cary Street Partners Investment Advisory's BIIB Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Biogen (BIIB) stake by 24% in Q2 2026, buying an estimated $13.2K and bringing the position to 353 shares worth $76.3K. The position accounts for 0.02% of the portfolio, ranked #539.

Cary Street Partners Investment Advisory first reported a position in BIIB in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.35M in Q3 2020. 711 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Cary Street Partners Investment Advisory held 353 shares of Biogen worth $76.3K as of Q2 2026.
Cary Street Partners Investment Advisory bought 69 Biogen shares in Q2 2026, an estimated $13.2K.
Biogen made up 0.02% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #539 holding.
Cary Street Partners Investment Advisory first reported a position in Biogen in Q3 2020 and has held it in 18 quarters since.
Cary Street Partners Investment Advisory's Biogen position peaked at $1.35M in Q3 2020.
711 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.